
1. mt sinai j med. 2006 nov;73(7):1037-44.

hiv-related pulmonary hypertension.

limsukon a(1), saeed ai, ramasamy v, nalamati j, dhuper s.

author information: 
(1)department internal medicine, bronx veterans affairs medical center, ny,
usa. atikhun@hotmail.com

with availability better treatment prophylactic regimens the
infectious complications human immunodeficiency virus (hiv), the
non-infectious complications gaining greater attention. hiv-related pulmonary
arterial hypertension (hiv-pah) one these. incidence hiv-pah is
estimated 0.5% hiv-infected individuals. pathogenesis remains unclear. 
patients present symptoms diverse progressive shortness breath,
pedal edema, dry cough, fatigue, syncope, well chest pain. chest x-ray
always shows cardiomegaly prominent pulmonary artery, evidence right
ventricular hypertrophy seen electrocardiogram. pulmonary
arterial systolic pressure, diastolic pressure pulmonary vascular resistance 
from right heart catheterization increased. small studies
showing benefit prostacyclin analog (epoprostenol iloprost) and
bosentan. role antiretrovirals remains controversial, other
agents calcium channel blockers anticoagulants. prognosis of
hiv-pah grave. two thirds hiv-pah related mortality usually secondary to
consequences pulmonary hypertension, worst survival noted new york
heart association (nyha) functional class iii-iv. probability survival 
one series 73%, 60% 47% one, two three years, respectively.


pmid: 17195895  [indexed medline]

